| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |